Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Liposomal doxorubicin with and without tamoxifen in the salvage treatment of high grade glioma – a phase II study

P Hau, J Dietrich, K Fabel, U Baumgart, O Grauer et al. Liposomal doxorubicin with and without tamoxifen in the salvage treatment of high grade glioma – a phase II study. Proceedings of the American Society of Clinical Oncology (ASCO) 38. 2002; 38:312.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.